1. Home
  2. BSEM

as of 08-31-2026 4:00pm EST

$3.68
+$0.15
+4.25%
Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Founded: N/A Country:
United States
United States
Employees: N/A City: POMPANO BEACH
Market Cap: 59.6M IPO Year: 2026
Target Price: N/A AVG Volume (30 days): 117.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.04 EPS Growth: N/A
52 Week Low/High: $2.25 - $4.66 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -3.39 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q2

Q2 2026 Earnings

8-K

Aug 12, 2026

0001193125-26-347211

Transcript text not available. View on SEC.gov →

Share on Social Networks: